Pregled bibliografske jedinice broj: 364393
Susceptibility to Telithromycin in 1, 011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries
Susceptibility to Telithromycin in 1, 011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries // Antimicrobial Agents and Chemotherapy, 46 (2002), 2; 546-549 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 364393 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Susceptibility to Telithromycin in 1, 011 Streptococcus pyogenes Isolates from 10 Central and Eastern European Countries
Autori
Nagai, K. ; Appelbaum, P. C. ; Davies, T. A. ; Kelly, L. M. ; Hoellman, D. B. ; Tambić Andrašević, Arjana ; Drukalska, L. ; Hryniewicz, W. ; Jacobs, M. R. ; Kolman, J. ; Miciuleviciene, J. ; Pana, M. ; Setchanova, L. ; Thege, M. K. ; Hupkova, H. ; Truplm J. ; Urbaskova, P.
Izvornik
Antimicrobial Agents and Chemotherapy (0066-4804) 46
(2002), 2;
546-549
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Group-a streptococci; Beta-hemolytic streptococci; Macrolide-resistance; Erythromycin resistance; Genes; Pneumococci; Mechanisms; Phenotypes; Ketolide; Strains
Sažetak
Among 1, 011 recently isolated Streptococcus pyogenes isolates from 10 Central and Eastern European centers, the MICs at which 50% of isolates are inhibited (MIC(50)s) and the MIC(90)s were as follows: for telithromycin, 0.03 and 0.06 microg/ml, respectively ; for erythromycin, azithromycin, and clarithromycin, 0.06 to 0.125 and 1 to 8 microg/ml, respectively ; and for clindamycin, 0.125 and 0.125 microg/ml, respectively. Erythromycin resistance occurred in 12.3% of strains. Erm(A) [subclass erm(TR)] was most commonly encountered (60.5%), followed by mef(A) (23.4%) and erm(B) (14.5%). At <0.5 microg/ml, telithromycin was active against 98.5% of the strains tested.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Profili:
Arjana Tambić-Andrašević
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE